MIODx, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
MIODx, Inc. operates in the biotechnology research sector with a focus on profiling an individual’s adaptive immune system over time. Its ClonoMap platform is used to characterize T cell diversity as a potential prognostic tool aimed at improving medical outcomes, signaling a data-driven approach to understanding immune response dynamics. The company targets institutions and researchers seeking insights into immune profiling to support personalized medicine and related clinical decision-making. Based in San Jose, California, MIODx is a small company positioned within a broader biotechnology landscape that includes other diagnostic and genomic firms. A notable recent development is the launch of ClonoMap Immune Profiler on DNAnexus Titan, which provides a cloud-enabled environment for sharing projects, data, and pipelines among approved team members.